Search - tctmd.com

Displaying 321 - 340 of 963

Sort: Relevancy | Date

Presentation TCT 2017

Impact of AUC and Public Reporting: Is PCI Now More Appropriate?

Presenter: Dean J. Kereiakes, Spencer B. King III, Michael A. Kutcher

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 4: NILE Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Ivo Petrov

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 3: BIOSS Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Ricardo A. Costa

October 30, 2017

Presentation TCT 2017

Metallic DES: What Can We Expect From New Drugs, Polymers, and Metals? Have We Reached the Limit of Iterative Development?

Presenter: Dean J. Kereiakes, Spencer B. King III, Elazer R. Edelman

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 2: AXXESS Plus Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Fausto Feres

October 30, 2017

Presentation TCT 2017

Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Stuart J. Pocock

October 30, 2017

Presentation TCT 2017

Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease?

Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic, Christophe Dubois

October 30, 2017

Presentation TCT 2017

New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us?

Presenter: Dean J. Kereiakes, Spencer B. King III, Aloke V. Finn

October 30, 2017

Presentation TCT 2017

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed?

Presenter: Paul A. Grayburn, Maurice E. Sarano, Robert J. Siegel

October 30, 2017

Presentation TCT 2017

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Presenter: Alaide Chieffo, Jeffrey W. Moses, Martin B. Leon

October 30, 2017

Presentation TCT 2017

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

Presenter: Dean J. Kereiakes, Spencer B. King III, Lorenz Raber

October 30, 2017

Presentation TCT 2017

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Laura Mauri

October 30, 2017

Presentation TCT 2017

Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go

Presenter: Dean J. Kereiakes, Spencer B. King III, Robert A. Byrne

October 30, 2017

Presentation TCT 2017

How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Sanjay Kaul

October 30, 2017

Presentation TCT 2017

PCI With DES and DEB for Treatment of "True" Coronary Artery Bifurcation Lesions

Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic, Jozica Sikic

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Sunil V. Rao

October 30, 2017

Presentation TCT 2017

Case #8: Bioresorbable Scaffold Implantation in Left Main Coronary Artery - Feasibility and Wisdom (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Rajiv Ananthakrishna

October 30, 2017

Presentation TCT 2017

Coronary Bifurcation Lesions: Do We Know the Optimal Strategy?

Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 1: The Onyx 2.0 Zotarolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Matthew J. Price

October 30, 2017

Presentation TCT 2017

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Presenter: Julinda Mehilli, Giulio G. Stefanini, Roxana Mehran

October 30, 2017

Advertisement

Impact of AUC and Public Reporting: Is PCI Now More Appropriate?

Bifurcation Stents 4: NILE Description, Data, and Case Examples

Bifurcation Stents 3: BIOSS Description, Data, and Case Examples

Metallic DES: What Can We Expect From New Drugs, Polymers, and Metals? Have We Reached the Limit of Iterative Development?

Bifurcation Stents 2: AXXESS Plus Description, Data, and Case Examples

Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others)

Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease?

New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us?

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed?

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go

How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others)

PCI With DES and DEB for Treatment of "True" Coronary Artery Bifurcation Lesions

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Case #8: Bioresorbable Scaffold Implantation in Left Main Coronary Artery - Feasibility and Wisdom (With Discussion)

Coronary Bifurcation Lesions: Do We Know the Optimal Strategy?

Small Vessel Stenting Snapshot 1: The Onyx 2.0 Zotarolimus-Eluting Stent

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content